Orris

My patient who had an emery lscs developed pph intraoperatively and underwent ligation of bilateral uterine arteries and chow sutures , postoperatively she was out on inj piptaz , inj amikacin , and inj metrogyl ,on pod 2 she develop abdominal distention which settled over 3 days , after 3 days she had multiple episode of loose stools and was thought to be due to metrogyl, and antibiotics were changed to meropenem and vancomycin but loose stools continued what could it be

Reading File
Finding Sources
Finding Sources
Searching PubMed

Clostridioides difficile AND antibiotic-associated diarrhea

Searching the Web

IDSA SHEA Clostridioides difficile infection diagnostic testing treatment guideline antibiotic associated diarrhea

Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading Web Page

https://www.idsociety.org/practice-guideline/clostridium-dif…

The leading concern is antibiotic-associated Clostridioides difficile infection (CDI), possibly evolving colitis, rather than metronidazole intolerance alone.
Why this fits:
  • She has had prolonged hospitalization, surgery, and exposure to several broad-spectrum antibiotics: piperacillin-tazobactam, amikacin, metronidazole, then meropenem and vancomycin.
  • CDI typically causes new watery diarrhea, often at least 3 unformed stools in 24 hours, during antibiotics or up to weeks afterward. Any antibiotic can precipitate it, including piperacillin-tazobactam, meropenem, and vancomycin. Current Surgical Therapy notes that CDI can also initially manifest with ileus and a dilated atonic bowel.
  • Switching to meropenem plus IV vancomycin may worsen intestinal microbiome disruption. IV vancomycin does not treat colonic CDI, because it does not achieve therapeutic intraluminal colonic concentrations.
Metronidazole itself can cause diarrhea, but persistent multiple loose stools after it has been stopped, in this setting, should not be attributed to metronidazole without excluding CDI.

Immediate clinical approach

  1. Institute contact precautions now: single room if possible, gloves/gown, soap-and-water handwashing, and sporicidal environmental cleaning.
  2. Send only an unformed stool sample for CDI testing:
    • NAAT/PCR for toxin gene plus toxin EIA, or your hospital's GDH-toxin algorithm.
    • Do not test formed stool and do not send a “test of cure.”
  3. Reassess whether any systemic antibiotic is still necessary. If infection treatment remains necessary, obtain cultures and de-escalate or stop nonessential agents with infectious-disease and obstetric-surgical input. Continuing the precipitating antibiotics reduces response and increases recurrence risk, per IDSA/SHEA guidance.
  4. Check severity and complications: vitals, fluid balance/urine output, CBC with WBC, creatinine, electrolytes, lactate, albumin, and abdominal examination.
  5. Given the preceding distension, obtain an urgent abdominal radiograph or CT abdomen/pelvis if there is recurrent distension, tenderness, fever, leukocytosis, rising lactate/creatinine, vomiting, or reduced stool/flatus. Evaluate for colitis, ileus, toxic megacolon, obstruction, pelvic collection/hematoma, bowel injury, or ischemic bowel.

If CDI is confirmed or strongly suspected

Treatment needs to be directed by the treating team, especially if she is septic or has ileus. For a non-fulminant initial CDI episode, current guidance favors oral fidaxomicin when available, with oral vancomycin an accepted alternative. For fulminant disease, defined by hypotension/shock, ileus, or toxic megacolon, oral/NG vancomycin plus IV metronidazole is generally used, with rectal vancomycin considered when ileus prevents delivery to the colon. IDSA/SHEA 2021 recommendations prefer fidaxomicin for routine initial CDI, resources permitting.
Do not use loperamide or other antimotility agents until CDI and obstruction/toxic megacolon have been assessed.
Other differentials remain possible:
  • Non-CDI antibiotic-associated diarrhea/dysbiosis
  • Viral gastroenteritis, especially norovirus
  • Laxative, magnesium, sorbitol-containing medication, or enteral-feed diarrhea
  • Less likely but important in this postoperative context: intra-abdominal/pelvic sepsis, bowel injury, partial obstruction with overflow, or ischemic colitis
The previous abdominal distension increases the urgency of excluding ileus or toxic megacolon. This warrants bedside review by the obstetric surgeon plus medicine/infectious disease, rather than simply further escalation of broad-spectrum antibiotics. Recent systematic reviews exist on prevention but do not alter this immediate diagnostic and management priority (PMIDs 40493294 and 40931979).

It has only been 6 days of hospitalization and distention has improved can it still be cdi

Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.